Jenna Sherry, MS

LID Clinical Studies Unit, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Bethesda, Maryland, United States

Disclosure(s): No financial relationships to disclose

Presentation(s):

• 593 - Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of the Safety of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine

  Saturday, October 19, 2024
  2:00 PM – 2:15 PM US PT